Selected research
Market Structure
Global Molecular Diagnostic Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Molecular Diagnostic Reagent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Molecular Diagnostic Reagent include Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Roche Diagnostics, Siemens AG, Qiagen, Illumina, Hologic and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Molecular Diagnostic Reagent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Molecular Diagnostic Reagent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Molecular Diagnostic Reagent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Molecular Diagnostic Reagent market size, projected growth trends, production technologies, key applications, and end-use industries.
Molecular Diagnostic Reagent Segment by Company
Abbott Laboratories
Thermo Fisher Scientific
Merck KGaA
Roche Diagnostics
Siemens AG
Qiagen
Illumina
Hologic
Grifols
Diasorin
Danaher Corporation
DaAn Gene
Bio-Rad Laboratories
Biomérieux Sa
Becton, Dickinson and Company
Agilent Technologies
Molecular Diagnostic Reagent Segment by Type
Polymerase Chain Reaction PCR
Gene chip
Gene Sequencing
Molecular Hybridization
Molecular Diagnostic Reagent Segment by Application
Infectious Disease Diagnosis
Genetic Diagnosis
Blood Screening
Other
Molecular Diagnostic Reagent Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostic Reagent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Molecular Diagnostic Reagent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostic Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Molecular Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polymerase Chain Reaction PCR
- Gene chip
- Gene Sequencing
- Molecular Hybridization
Applications
- Infectious Disease Diagnosis
- Genetic Diagnosis
- Blood Screening
- Other
Companies covered
- Abbott Laboratories
- Thermo Fisher Scientific
- Merck KGaA
- Roche Diagnostics
- Siemens AG
- Qiagen
- Illumina
- Hologic
- Grifols
- Diasorin
- Danaher Corporation
- DaAn Gene
- Bio-Rad Laboratories
- Biomérieux Sa
- Becton, Dickinson and Company
- Agilent Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Molecular Diagnostic Reagent Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Molecular Diagnostic Reagent Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Molecular Diagnostic Reagent Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Molecular Diagnostic Reagent Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Molecular Diagnostic Reagent Market Dynamics
- 2.1 Molecular Diagnostic Reagent Industry Trends
- 2.2 Molecular Diagnostic Reagent Industry Drivers
- 2.3 Molecular Diagnostic Reagent Industry Opportunities and Challenges
- 2.4 Molecular Diagnostic Reagent Industry Restraints
3 Molecular Diagnostic Reagent Market by Manufacturers
- 3.1 Global Molecular Diagnostic Reagent Revenue by Manufacturers (2021-2026)
- 3.2 Global Molecular Diagnostic Reagent Sales by Manufacturers (2021-2026)
- 3.3 Global Molecular Diagnostic Reagent Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Molecular Diagnostic Reagent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Molecular Diagnostic Reagent Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Molecular Diagnostic Reagent Manufacturers, Product Type & Application
- 3.7 Global Molecular Diagnostic Reagent Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Molecular Diagnostic Reagent Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Molecular Diagnostic Reagent Players Market Share by Revenue in 2025
- 3.8.3 2025 Molecular Diagnostic Reagent Tier 1, Tier 2, and Tier 3
4 Molecular Diagnostic Reagent Market by Type
- 4.1 Molecular Diagnostic Reagent Type Introduction
- 4.1.1 Polymerase Chain Reaction PCR
- 4.1.2 Gene chip
- 4.1.3 Gene Sequencing
- 4.1.4 Molecular Hybridization
- 4.2 Global Molecular Diagnostic Reagent Sales by Type
- 4.2.1 Global Molecular Diagnostic Reagent Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Molecular Diagnostic Reagent Sales by Type (2021-2032)
- 4.2.3 Global Molecular Diagnostic Reagent Sales Market Share by Type (2021-2032)
- 4.3 Global Molecular Diagnostic Reagent Revenue by Type
- 4.3.1 Global Molecular Diagnostic Reagent Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Molecular Diagnostic Reagent Revenue by Type (2021-2032)
- 4.3.3 Global Molecular Diagnostic Reagent Revenue Market Share by Type (2021-2032)
5 Molecular Diagnostic Reagent Market by Application
- 5.1 Molecular Diagnostic Reagent Application Introduction
- 5.1.1 Infectious Disease Diagnosis
- 5.1.2 Genetic Diagnosis
- 5.1.3 Blood Screening
- 5.1.4 Other
- 5.2 Global Molecular Diagnostic Reagent Sales by Application
- 5.2.1 Global Molecular Diagnostic Reagent Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Molecular Diagnostic Reagent Sales by Application (2021-2032)
- 5.2.3 Global Molecular Diagnostic Reagent Sales Market Share by Application (2021-2032)
- 5.3 Global Molecular Diagnostic Reagent Revenue by Application
- 5.3.1 Global Molecular Diagnostic Reagent Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Molecular Diagnostic Reagent Revenue by Application (2021-2032)
- 5.3.3 Global Molecular Diagnostic Reagent Revenue Market Share by Application (2021-2032)
6 Global Molecular Diagnostic Reagent Sales by Region
- 6.1 Global Molecular Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Molecular Diagnostic Reagent Sales by Region (2021-2032)
- 6.2.1 Global Molecular Diagnostic Reagent Sales by Region (2021-2026)
- 6.2.2 Global Molecular Diagnostic Reagent Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Molecular Diagnostic Reagent Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Molecular Diagnostic Reagent Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Molecular Diagnostic Reagent Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Molecular Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Molecular Diagnostic Reagent Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Molecular Diagnostic Reagent Revenue by Region
- 7.1 Global Molecular Diagnostic Reagent Revenue by Region
- 7.1.1 Global Molecular Diagnostic Reagent Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Molecular Diagnostic Reagent Revenue by Region (2021-2026)
- 7.1.3 Global Molecular Diagnostic Reagent Revenue by Region (2027-2032)
- 7.1.4 Global Molecular Diagnostic Reagent Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Molecular Diagnostic Reagent Revenue (2021-2032)
- 7.2.2 North America Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Molecular Diagnostic Reagent Revenue (2021-2032)
- 7.3.2 Europe Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Molecular Diagnostic Reagent Revenue (2021-2032)
- 7.4.2 Asia-Pacific Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Molecular Diagnostic Reagent Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Molecular Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Information
- 8.1.2 Abbott Laboratories Business Overview
- 8.1.3 Abbott Laboratories Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Laboratories Molecular Diagnostic Reagent Product Portfolio
- 8.1.5 Abbott Laboratories Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Molecular Diagnostic Reagent Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Merck KGaA
- 8.3.1 Merck KGaA Company Information
- 8.3.2 Merck KGaA Business Overview
- 8.3.3 Merck KGaA Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck KGaA Molecular Diagnostic Reagent Product Portfolio
- 8.3.5 Merck KGaA Recent Developments
- 8.4 Roche Diagnostics
- 8.4.1 Roche Diagnostics Company Information
- 8.4.2 Roche Diagnostics Business Overview
- 8.4.3 Roche Diagnostics Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Roche Diagnostics Molecular Diagnostic Reagent Product Portfolio
- 8.4.5 Roche Diagnostics Recent Developments
- 8.5 Siemens AG
- 8.5.1 Siemens AG Company Information
- 8.5.2 Siemens AG Business Overview
- 8.5.3 Siemens AG Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Siemens AG Molecular Diagnostic Reagent Product Portfolio
- 8.5.5 Siemens AG Recent Developments
- 8.6 Qiagen
- 8.6.1 Qiagen Company Information
- 8.6.2 Qiagen Business Overview
- 8.6.3 Qiagen Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Qiagen Molecular Diagnostic Reagent Product Portfolio
- 8.6.5 Qiagen Recent Developments
- 8.7 Illumina
- 8.7.1 Illumina Company Information
- 8.7.2 Illumina Business Overview
- 8.7.3 Illumina Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Illumina Molecular Diagnostic Reagent Product Portfolio
- 8.7.5 Illumina Recent Developments
- 8.8 Hologic
- 8.8.1 Hologic Company Information
- 8.8.2 Hologic Business Overview
- 8.8.3 Hologic Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Hologic Molecular Diagnostic Reagent Product Portfolio
- 8.8.5 Hologic Recent Developments
- 8.9 Grifols
- 8.9.1 Grifols Company Information
- 8.9.2 Grifols Business Overview
- 8.9.3 Grifols Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Grifols Molecular Diagnostic Reagent Product Portfolio
- 8.9.5 Grifols Recent Developments
- 8.10 Diasorin
- 8.10.1 Diasorin Company Information
- 8.10.2 Diasorin Business Overview
- 8.10.3 Diasorin Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Diasorin Molecular Diagnostic Reagent Product Portfolio
- 8.10.5 Diasorin Recent Developments
- 8.11 Danaher Corporation
- 8.11.1 Danaher Corporation Company Information
- 8.11.2 Danaher Corporation Business Overview
- 8.11.3 Danaher Corporation Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Danaher Corporation Molecular Diagnostic Reagent Product Portfolio
- 8.11.5 Danaher Corporation Recent Developments
- 8.12 DaAn Gene
- 8.12.1 DaAn Gene Company Information
- 8.12.2 DaAn Gene Business Overview
- 8.12.3 DaAn Gene Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 DaAn Gene Molecular Diagnostic Reagent Product Portfolio
- 8.12.5 DaAn Gene Recent Developments
- 8.13 Bio-Rad Laboratories
- 8.13.1 Bio-Rad Laboratories Company Information
- 8.13.2 Bio-Rad Laboratories Business Overview
- 8.13.3 Bio-Rad Laboratories Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Bio-Rad Laboratories Molecular Diagnostic Reagent Product Portfolio
- 8.13.5 Bio-Rad Laboratories Recent Developments
- 8.14 Biomérieux Sa
- 8.14.1 Biomérieux Sa Company Information
- 8.14.2 Biomérieux Sa Business Overview
- 8.14.3 Biomérieux Sa Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Biomérieux Sa Molecular Diagnostic Reagent Product Portfolio
- 8.14.5 Biomérieux Sa Recent Developments
- 8.15 Becton, Dickinson and Company
- 8.15.1 Becton, Dickinson and Company Company Information
- 8.15.2 Becton, Dickinson and Company Business Overview
- 8.15.3 Becton, Dickinson and Company Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Becton, Dickinson and Company Molecular Diagnostic Reagent Product Portfolio
- 8.15.5 Becton, Dickinson and Company Recent Developments
- 8.16 Agilent Technologies
- 8.16.1 Agilent Technologies Company Information
- 8.16.2 Agilent Technologies Business Overview
- 8.16.3 Agilent Technologies Molecular Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Agilent Technologies Molecular Diagnostic Reagent Product Portfolio
- 8.16.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Molecular Diagnostic Reagent Value Chain Analysis
- 9.1.1 Molecular Diagnostic Reagent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Molecular Diagnostic Reagent Production Mode & Process
- 9.2 Molecular Diagnostic Reagent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Molecular Diagnostic Reagent Distributors
- 9.2.3 Molecular Diagnostic Reagent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst